• 2011

Company Description

Bullet Biotechnology is biotech company developing products that improve a patient's immune system to fight diseases.

Bullet Biotechnology is an innovative biotech company developing powerful products which will train a patient's own immune system to fight disease. Using our proprietary protein nanoparticles, we create powerful immunotherapies to target cancer. Our initial product dramatically improves response rates to checkpoint inhibitors such as anti-PD1 and anti-CTLA4, and will be developed for solid tumors. Bullet Biotech’s experienced management team is taking a practical approach to building and realizing value for patients and investors.